NCT00835120 Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance Status COMPLETED Phase PHASE4
NCT00820807 Effects of Novel Fiber on Glucose Homeostasis in Individuals at Risk for Diabetes Status TERMINATED Phase NA
NCT00820651 Efficacy and Safety of Diamel in Patients With Nonalcoholic Steatohepatitis Status COMPLETED Phase PHASE3
NCT00784745 Is Insulin Resistance and/or Glucose Intolerance Pathogenetic in the Development of a Reduced Incretin Effect Status COMPLETED Phase NA
NCT00782795 Chronic Pancreatitis. Effect of Pioglitazone on Endocrine Function, Exocrine Function & Structure, Pain & Life Quality Status COMPLETED Phase PHASE2
NCT00775164 Pioglitazone Therapy in Obese Children With Insulin Resistance: A Randomized, Controlled Pilot Study Status WITHDRAWN Phase PHASE4
NCT00755742 Lifestyle Intervention Targetting Obesity and Insulin Resistance in Chronic Hepatitis C Status COMPLETED Phase NA
NCT00755456 Effect of an L-carnitine-containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD) Status COMPLETED Phase PHASE2
NCT00741026 A Crossover Study of the Acute Effects of Olanzapine in Healthy Volunteers Status COMPLETED Phase NA
NCT00724087 Sleep Loss and Energy Metabolism in People With Family History of Type 2 Diabetes. Status COMPLETED Phase NA
NCT00721019 Sleep Loss and Glucose Metabolism in People With Family History of Type 2 Diabetes. Status COMPLETED Phase NA
NCT00720889 Glucose Metabolism and Sleep in People With Family History of Type 2 Diabetes. Status COMPLETED Phase N/A